Key result
Curative surgery for Cushing's syndrome is linked to further blood lipid deterioration during early remission.
Why the study?
Does curative surgery for Cushing's syndrome improve lipid profiles during early postoperative remission?
Cohort (n=52)
No
Does curative surgery for Cushing's syndrome improve lipid profiles during early postoperative remission?
Lipid parameters paradoxically deteriorate during the early remission phase following curative surgery for Cushing's syndrome, highlighting a period of increased cardiovascular vulnerability.
CONTEXT: Cushing's syndrome (CS) is associated with an unfavorable lipid profile. However, data on lipid alterations during early postoperative remission, a particularly cardiovascular vulnerable period, are lacking. OBJECTIVE: Evaluation of lipid profiles during active CS and the early postoperative period. PATIENTS AND METHODS: In this single-center cohort study at LMU Hospital, Munich, we analyzed lipid profiles (total cholesterol, LDL, HDL, ApoA1, ApoB, lipoprotein (a), triglycerides, and non-esterified fatty acids) and metabolic markers in 26 patients with endogenous CS before surgery and 1, 3, 6, 12 and 24 months (n = 23) after curative surgery and compared them with 26 age-, BMI-, and sex-matched controls without hypercortisolism at baseline. RESULTS: Paradoxically, most lipid parameters worsened postoperatively. One month following surgery, HDL (1 month postoperative 38 mg/dL [35-46] vs. active CS 49.5 mg/dL [45-61.3], P < .0001) and ApoA1 concentrations (1-month postoperative 160 mg/dL [147-168] vs. active CS 193 mg/dL [169-211], P < .0001) were significantly lower compared to preoperative levels. Similarly, 1-month following surgery triglycerides concentrations (1-month postoperative 185 mg/dL [154-218] vs. active CS 129 mg/dL [89.3-186] preoperatively, P < .0001) were higher. These changes remained evident until 6 months post-surgery. The triglyceride-glucose index increased during early remission and showed a positive correlation with inflammatory markers CRP and IL-6. Non-esterified fatty acids displayed 3 distinct postoperative trajectories depending on BMI at baseline. CONCLUSION: During the early remission phase following curative surgery for CS, we observed a further deterioration in lipid parameters. This can affect cardiovascular health and provide the basis for targeted therapy.
No takes yet. Share an insight, caveat, or question.
Schrenk et al. (2026) conducted a cohort in Cushing's syndrome (n=52). Early postoperative remission following curative surgery vs. Active Cushing's syndrome (preoperative levels) was evaluated on Lipid profiles (HDL, ApoA1, triglycerides) (p=<.0001). Early postoperative remission of Cushing's syndrome was associated with paradoxical worsening of lipids, including a decrease in HDL from 49.5 to 38 mg/dL at 1 month (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: